Company / Interest Expense per Share
IGC Pharma, Inc. Interest Expense per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2020-FY2024
Trend
-3.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of +7.3%.
Improved from $0.00 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, interest expense per share decreased 3.8% year-over-year.
- Peak interest expense per share was recorded in FY2016.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -3.8% |
| FY2023 | $0.00 | -6.3% |
| FY2022 | $0.00 | +37.0% |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.01 | -14.0% |
| FY2017 | $0.01 | -95.8% |
| FY2016 | $0.22 | -1.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026